Published on 28 May 2024 on Benzinga via Yahoo Finance
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
On Tuesday, Vivani Medical Inc (NASDAQ:VANI) announced the publication of positive proof-of-concept weight loss data with OKV-119 to treat feline obesity and diabetes in the peer-reviewed BMC Veterinary Research.
OKV-119 is a miniature, subdermal, exenatide drug implant.